Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects.


Journal

The American journal of drug and alcohol abuse
ISSN: 1097-9891
Titre abrégé: Am J Drug Alcohol Abuse
Pays: England
ID NLM: 7502510

Informations de publication

Date de publication:
2019
Historique:
pubmed: 15 1 2019
medline: 15 5 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects. A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers. Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence. The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.

Sections du résumé

BACKGROUND
Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.
OBJECTIVES
To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.
METHODS
A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.
RESULTS
Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.
CONCLUSIONS
The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.

Identifiants

pubmed: 30640573
doi: 10.1080/00952990.2018.1559849
doi:

Substances chimiques

Central Nervous System Stimulants 0
Methamphetamine 44RAL3456C
Ketamine 690G0D6V8H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-284

Auteurs

Huixi Dong (H)

a Mental Health Center of Xiangya Hospital , Central South University , Changsha , Hunan , China.
b Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital , Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health , Changsha , Hunan , China.

Cheng Yang (C)

b Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital , Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health , Changsha , Hunan , China.

Yidong Shen (Y)

b Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital , Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health , Changsha , Hunan , China.

Liang Liu (L)

c Wuxi Mental Health Center , Nanjing Medical University , Wuxi , Jiangsu , China.

Mengqi Liu (M)

b Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital , Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health , Changsha , Hunan , China.

Wei Hao (W)

b Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital , Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health , Changsha , Hunan , China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH